InvestorsHub Logo

dmort545

01/04/16 1:19 PM

#23155 RE: cvinvestor #23154

IF RGEN were to be bought out,BATU would be a good fall back position for the Ichims since they could reinvest their new wealth.

Schuller

01/04/16 1:22 PM

#23156 RE: cvinvestor #23154

Or maybe he didn't like taking a back seat to Dr Lander who obviously has a higher business IQ and can further the company much better. EGO'S the ruin of man.

Regards!!!

Kryo

01/04/16 1:51 PM

#23157 RE: cvinvestor #23154

Thanks for your well put thoughts. So my take away from your post are two good things, namely NR2F6 being developed by Christine Ichim (who hopefully stays at RGBP a litter longer) and dCellVax being further researched by Dr. Kesari.

Feeling better right now :-)

mrMando

01/04/16 2:29 PM

#23160 RE: cvinvestor #23154

I do agree with your piecing together.
My disruptive thought right now, though, is the very strong circumstantial facts that point to this "illness" pr. being an outright low blow to investors and misleading investors with a potential lie no matter what the reason was. And with that, it was news that had an unfavorable sentiment as well. I BY NO MEANS AM A BUSINESS LAWER, but this would be almost inline with a class action lawsuit.
I really really do not want to be viewed as a b@sher here, as I am very much invested and support the progress, but this one thing I need some closure on. The seed of deceit has been planted and I am all for understanding more about this if I am wrong. I would rather be wrong about it all. More positive developments and hopefully more transparency of T. Ichim's actual role here will reassure me .

Sorry to be such a bummer today longs...